19-38528963-CAGGAGGAGG-CAGGAGG
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP3BP6
The NM_000540.3(RYR1):c.11061_11063del(p.Glu3689del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.00068 in 1,581,278 control chromosomes in the GnomAD database, including 3 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00062 ( 3 hom. )
Consequence
RYR1
NM_000540.3 inframe_deletion
NM_000540.3 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.54
Genes affected
RYR1 (HGNC:10483): (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP3
?
Nonframeshift variant in repetitive region in NM_000540.3
BP6
?
Variant 19-38528963-CAGG-C is Benign according to our data. Variant chr19-38528963-CAGG-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 218465.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=4, Benign=2}. Variant chr19-38528963-CAGG-C is described in Lovd as [Likely_benign].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RYR1 | NM_000540.3 | c.11061_11063del | p.Glu3689del | inframe_deletion | 76/106 | ENST00000359596.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RYR1 | ENST00000359596.8 | c.11061_11063del | p.Glu3689del | inframe_deletion | 76/106 | 5 | NM_000540.3 | A2 |
Frequencies
GnomAD3 genomes ? AF: 0.00122 AC: 185AN: 151988Hom.: 0 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
185
AN:
151988
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000623 AC: 891AN: 1429174Hom.: 3 AF XY: 0.000607 AC XY: 431AN XY: 710134
GnomAD4 exome
AF:
AC:
891
AN:
1429174
Hom.:
AF XY:
AC XY:
431
AN XY:
710134
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.00122 AC: 185AN: 152104Hom.: 0 Cov.: 32 AF XY: 0.00116 AC XY: 86AN XY: 74356
GnomAD4 genome
?
AF:
AC:
185
AN:
152104
Hom.:
Cov.:
32
AF XY:
AC XY:
86
AN XY:
74356
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
RYR1-related disorder Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 29, 2024 | The RYR1 c.11061_11063delGGA variant is predicted to result in an in-frame deletion (p.Glu3689del). This variant has been reported in two individuals with no history of malignant hyperthermia, heat illness, or myopathy (Table S3 - Gonsalves et al. 2013. PubMed ID: 24195946). This variant was also reported in an individual with hypertrophied muscles and persistently elevated serum creatine kinase (Vedanarayanan. American Academy of Neurology 2013 Annual Meeting; https://www.aan.com/MSA/Public/Events/Details/2786). This variant is reported in 1.8% of alleles in individuals of Ashkenazi Jewish descent in gnomAD; however, quality metrics at this site indicate this may not be a reliable estimate of the population frequency. At PreventionGenetics, we have observed this variant in the heterozygous state in ~90 individuals indicating it is likely too common to be a primary cause of an autosomal dominant disorder. Although we suspect this variant is benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Malignant hyperthermia, susceptibility to, 1 Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | research | Biesecker Lab/Clinical Genomics Section, National Institutes of Health | Jul 01, 2013 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Mar 28, 2019 | - - |
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 09, 2023 | Identified as a heterozygous variant in a cohort of African American men with muscle cramps and pain with exertion (Vedanarayanan and Sinclair, 2013); In silico analysis supports a deleterious effect on protein structure/function - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | RYR1: BS1, BS2 - |
Malignant hypothermia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia | Apr 17, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at